Deborah Stewart Sells 11,962 Shares of Aveanna Healthcare (NASDAQ:AVAH) Stock

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) CAO Deborah Stewart sold 11,962 shares of the stock in a transaction that occurred on Friday, January 2nd. The stock was sold at an average price of $7.85, for a total transaction of $93,901.70. Following the completion of the transaction, the chief accounting officer owned 251,676 shares in the company, valued at $1,975,656.60. The trade was a 4.54% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this link.

Deborah Stewart also recently made the following trade(s):

• On Wednesday, December 31st, Deborah Stewart sold 11,275 shares of Aveanna Healthcare stock. The shares were sold at an average price of $8.18, for a total transaction of $92,229.50.
• On Tuesday, December 30th, Deborah Stewart sold 11,379 shares of Aveanna Healthcare stock. The stock was sold at an average price of $8.36, for a total value of $95,128.44.

Aveanna Healthcare Price Performance

NASDAQ AVAH opened at $8.08 on Friday. The business’s fifty day moving average is $8.92 and its 200 day moving average is $7.51. Aveanna Healthcare Holdings Inc. has a fifty-two week low of $3.67 and a fifty-two week high of $10.32. The company has a debt-to-equity ratio of 140.39, a quick ratio of 1.23 and a current ratio of 1.23. The company has a market capitalization of $1.69 billion, a PE ratio of 22.44 and a beta of 2.06.

Aveanna Healthcare (NASDAQ:AVAH) last posted its quarterly earnings data on Monday, May 22nd. The company reported $0.04 EPS for the quarter. Aveanna Healthcare had a negative return on equity of 143.55% and a net margin of 3.29%.The firm had revenue of $450.53 million for the quarter. Sell-side analysts predict that Aveanna Healthcare Holdings Inc. will post -0.06 earnings per share for the current year.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in AVAH. Summit Partners L P purchased a new stake in shares of Aveanna Healthcare in the second quarter worth about $50,477,000. Vanguard Group Inc. increased its stake in Aveanna Healthcare by 34.7% in the 3rd quarter. Vanguard Group Inc. now owns 4,041,659 shares of the company’s stock worth $35,850,000 after acquiring an additional 1,041,324 shares during the last quarter. AustralianSuper Pty Ltd purchased a new stake in shares of Aveanna Healthcare during the 3rd quarter worth approximately $15,743,000. Connor Clark & Lunn Investment Management Ltd. boosted its position in shares of Aveanna Healthcare by 70.1% during the 3rd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 1,130,912 shares of the company’s stock valued at $10,031,000 after acquiring an additional 466,022 shares during the last quarter. Finally, Algert Global LLC grew its holdings in shares of Aveanna Healthcare by 120.1% in the third quarter. Algert Global LLC now owns 1,022,599 shares of the company’s stock valued at $9,070,000 after purchasing an additional 557,898 shares in the last quarter. Hedge funds and other institutional investors own 87.96% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on AVAH. UBS Group increased their price objective on shares of Aveanna Healthcare from $9.00 to $9.50 and gave the stock a “neutral” rating in a research note on Friday, November 7th. Raymond James Financial reaffirmed an “outperform” rating and issued a $13.00 target price on shares of Aveanna Healthcare in a report on Friday, December 5th. Weiss Ratings reissued a “hold (c+)” rating on shares of Aveanna Healthcare in a report on Monday, December 29th. Truist Financial upped their price objective on Aveanna Healthcare from $9.50 to $10.00 and gave the stock a “hold” rating in a research note on Friday, November 7th. Finally, JPMorgan Chase & Co. raised Aveanna Healthcare from an “underweight” rating to a “neutral” rating and lifted their target price for the company from $6.00 to $10.00 in a research note on Thursday, September 18th. Five equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average target price of $10.69.

Key Stores Impacting Aveanna Healthcare

Here are the key news stories impacting Aveanna Healthcare this week:

• Negative Sentiment: CEO Jeff Shaner sold multiple blocks (roughly 83,000+ shares across Dec. 30–Jan. 2 in the filings), at prices around $8.18–$8.36, reducing his stake by about 1–1.2% in individual trades while retaining a multi‑million‑share holding — investors may view repeated CEO sales as a negative signal. SEC filing — Jeff Shaner
• Negative Sentiment: CFO Matthew Buckhalter executed several sales (totaling ~70,000+ shares across Dec. 30–Jan. 2) at roughly $7.85–$8.36, each reducing his position by ~3.5–4%. Repeated CFO sales can raise governance/comfort concerns for short‑term holders. SEC filing — Matthew Buckhalter
• Negative Sentiment: CAO Deborah Stewart sold multiple blocks (~34,000+ shares across Dec. 30–Jan. 2) at similar price levels, trimming her stake by ~4% in reported trades while keeping a substantial holding — another senior exec sale that may pressure sentiment. SEC filing — Deborah Stewart
• Negative Sentiment: Insider Edwin C. Reisz sold multiple tranches (~51,000+ shares across Dec. 30–Jan. 2) at $7.85–$8.36, reducing his position by ~1.2% in several filings. Multiple insider sellers across ranks amplify negative interpretation. SEC filing — Edwin C. Reisz
• Negative Sentiment: Insider Patrick A. Cunningham reported several sales (~36,000+ shares across Dec. 30–Jan. 2) at similar price points, lowering his stake by ~3.6–4.1% in the disclosed trades. Collective insider selling increases perceived supply risk. SEC filing — Patrick A. Cunningham

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.